中國核電(601985.SH):中核匯能擬以2.98億元收購鑲黃旗能源100%股權
格隆匯9月22日丨中國核電(601985.SH)公佈,公司控股子公司中核匯能有限公司(簡稱中核匯能)擬與協鑫能源科技股份有限公司(簡稱協鑫能科)下屬控股子公司協鑫智慧(蘇州)能源電力投資有限公司(簡稱蘇州協鑫)簽訂股權轉讓協議,以人民幣2.98億元的價格受讓蘇州協鑫持有的錫林郭勒盟鑲黃旗協鑫能源有限公司(簡稱鑲黃旗協鑫、鑲黃旗能源、標的公司、目標公司)100%股權。
此次股權轉讓完成後,公司下屬控股子公司中核匯能成為鑲黃旗能源的股控股股東,公司合併報表範圍發生變更,鑲黃旗能源納入公司合併報表範圍。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.